These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37933021)

  • 21. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
    Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
    J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea.
    Seo BS; Roh JH; Lee JH; Lee H; Min Kim Y; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e375-e382. PubMed ID: 33731579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
    Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
    Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
    Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Yang HJ; Chang Y; Park SK; Jung YS; Park JH; Park DI; Cho YK; Ryu S; Sohn CI
    Dig Dis Sci; 2017 Dec; 62(12):3605-3613. PubMed ID: 29063416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
    Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
    Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
    Miptah HN; Ramli AS; Mohamad M; Hashim H; Tharek Z
    BMC Fam Pract; 2020 Nov; 21(1):238. PubMed ID: 33218301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.
    Ishido S; Tamaki N; Takahashi Y; Uchihara N; Suzuki K; Tanaka Y; Miyamoto H; Yamada M; Matsumoto H; Nobusawa T; Keitoku T; Takaura K; Tanaka S; Maeyashiki C; Yasui Y; Tsuchiya K; Nakanishi H; Kurosaki M; Izumi N
    BMC Gastroenterol; 2023 Jun; 23(1):211. PubMed ID: 37330485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults.
    Park KY; Hwang HS; Han K; Park HK
    Am J Prev Med; 2024 Apr; 66(4):717-724. PubMed ID: 38008134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.
    Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):49-58. PubMed ID: 35968564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).
    George ES; Georgousopoulou EN; Mellor DD; Chrysohoou C; Pitsavos C; Panagiotakos DB
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.
    Cho HJ; Hwang S; Park JI; Yang MJ; Hwang JC; Yoo BM; Lee KM; Shin SJ; Lee KJ; Kim JH; Cheong JY; Cho SW; Kim SS
    Gut Liver; 2019 Apr; 13(4):440-449. PubMed ID: 30970431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.
    Corey KE; Kartoun U; Zheng H; Chung RT; Shaw SY
    Am J Gastroenterol; 2016 May; 111(5):671-6. PubMed ID: 26925881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Janjua M; Knuiman M; Divitini M; McQuillan B; Olynyk JK; Jeffrey GP; Adams LA
    Hepatol Commun; 2022 Mar; 6(3):526-534. PubMed ID: 34931492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association between Nonalcoholic Fatty Liver Disease and Stroke: Results from the Korean Genome and Epidemiology Study (KoGES).
    Yang YJ; Jung MH; Jeong SH; Hong YP; Kim YI; An SJ
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33371282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.
    Sharma D; Gotlieb N; Farkouh ME; Patel K; Xu W; Bhat M
    J Am Heart Assoc; 2022 Jan; 11(1):e022576. PubMed ID: 34927450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.